The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Table of Contents
Global Cancer Drugs Market Professional Survey Report 2019
1 Report Overview
1.1 Definition and Specification
1.2 Manufacturers and Region Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.3.1 Chemotherapy
1.3.2 Targeted Therapy
1.3.3 Immunotherapy
1.3.4 Hormonal Therapy (Biologic Therapy)
1.3.5 Others
1.4 Application Overview
1.4.1 Blood Cancer
1.4.2 Breast Cancer
1.4.3 Gastrointestinal Cancer
1.4.4 Prostate Cancer
1.4.5 Respiratory/Lung Cancer
1.4.6 Other Cancers
1.5 Industrial Chain
1.5.1 Cancer Drugs Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
2.1 The Overall Market Performance(Volume)
2.1.1 Chemotherapy
2.1.2 Targeted Therapy
2.1.3 Immunotherapy
2.1.4 Hormonal Therapy (Biologic Therapy)
2.1.5 Others
2.2 The Overall Market Performance(Value)
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy
2.2.4 Hormonal Therapy (Biologic Therapy)
2.2.5 Others
3 Global Cancer Drugs Market Assessment by Application
3.1 Overall Market Performance (Volume)
3.2 Blood Cancer
3.3 Breast Cancer
3.4 Gastrointestinal Cancer
3.5 Prostate Cancer
3.6 Respiratory/Lung Cancer
3.7 Other Cancers
4 Competitive Analysis
4.1 Roche
4.1.1 Roche Profiles
4.1.2 Roche Product Information
4.1.3 Roche Cancer Drugs Business Performance
4.1.4 SWOT Analysis
4.2 Novartis
4.2.1 Novartis Profiles
4.2.2 Novartis Product Information
4.2.3 Novartis Cancer Drugs Business Performance
4.2.4 SWOT Analysis
4.3 Celgene
4.3.1 Celgene Profiles
4.3.2 Celgene Product Information
4.3.3 Celgene Cancer Drugs Business Performance
4.3.4 SWOT Analysis
4.4 Bristol-Myers Squibb
4.4.1 Bristol-Myers Squibb Profiles
4.4.2 Bristol-Myers Squibb Product Information
4.4.3 Bristol-Myers Squibb Cancer Drugs Business Performance
4.4.4 SWOT Analysis
4.5 Amgen
4.5.1 Amgen Profiles
4.5.2 Amgen Product Information
4.5.3 Amgen Cancer Drugs Business Performance
4.5.4 SWOT Analysis
4.6 Johnson & Johnson
4.6.1 Johnson & Johnson Profiles
4.6.2 Johnson & Johnson Product Information
4.6.3 Johnson & Johnson Cancer Drugs Business Performance
4.6.4 SWOT Analysis
4.7 Pfizer
4.7.1 Pfizer Profiles
4.7.2 Pfizer Product Information
4.7.3 Pfizer Cancer Drugs Business Performance
4.7.4 SWOT Analysis
4.8 Takeda
4.8.1 Takeda Profiles
4.8.2 Takeda Product Information
4.8.3 Takeda Cancer Drugs Business Performance
4.8.4 SWOT Analysis
4.9 Eli Lilly
4.9.1 Eli Lilly Profiles
4.9.2 Eli Lilly Product Information
4.9.3 Eli Lilly Cancer Drugs Business Performance
4.9.4 SWOT Analysis
4.10 AstraZeneca
4.10.1 AstraZeneca Profiles
4.10.2 AstraZeneca Product Information
4.10.3 AstraZeneca Cancer Drugs Business Performance
4.10.4 SWOT Analysis
4.11 Astellas
4.12 Merck & Co.
4.13 Sanofi
4.14 Bayer
4.15 Biogen Idec
4.16 Eisai
4.17 Teva
4.18 Otsuka
4.19 Merck KGaA
4.20 Ipsen
4.21 AbbVie
4.22 Gilead Sciences
5 Competitive Lanscape
5.1 Global Cancer Drugs Capacity (K Units) and Market Share of Manufacturers (2014-2020)
5.2 Global Cancer Drugs Sales (K Units) and Market Share of Manufacturers (2014-2020)
5.3 Global Cancer Drugs Revenue (M USD) and Market Share of Manufacturers (2014-2020)
5.4 Global Cancer Drugs Price (USD/Unit) of Manufacturers (2014-2020)
5.5 Global Cancer Drugs Gross Margin of Manufacturers (2014-2020)
5.6 Market Concentration
6 Regional Market Analysis
6.1 China Market Performance for Manufacturers
6.1.1 China Cancer Drugs Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.1.2 China Cancer Drugs Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.1.3 China Cancer Drugs Price (USD/Unit) of Manufacturers (2014-2020)
6.1.4 China Cancer Drugs Gross Margin of Manufacturers (2014-2020)
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Cancer Drugs Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.2.2 USA Cancer Drugs Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.2.3 USA Cancer Drugs Price (USD/Unit) of Manufacturers (2014-2020)
6.2.4 USA Cancer Drugs Gross Margin of Manufacturers (2014-2020)
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Cancer Drugs Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.3.2 Europe Cancer Drugs Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.3.3 Europe Cancer Drugs Price (USD/Unit) of Manufacturers (2014-2020)
6.3.4 Europe Cancer Drugs Gross Margin of Manufacturers (2014-2020)
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Cancer Drugs Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.4.2 Japan Cancer Drugs Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.4.3 Japan Cancer Drugs Price (USD/Unit) of Manufacturers (2014-2020)
6.4.4 Japan Cancer Drugs Gross Margin of Manufacturers (2014-2020)
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Cancer Drugs Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.5.2 Korea Cancer Drugs Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.5.3 Korea Cancer Drugs Price (USD/Unit) of Manufacturers (2014-2020)
6.5.4 Korea Cancer Drugs Gross Margin of Manufacturers (2014-2020)
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Cancer Drugs Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.6.2 India Cancer Drugs Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.6.3 India Cancer Drugs Price (USD/Unit) of Manufacturers (2014-2020)
6.6.4 India Cancer Drugs Gross Margin of Manufacturers (2014-2020)
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Cancer Drugs Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.7.2 Southeast Asia Cancer Drugs Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.7.3 Southeast Asia Cancer Drugs Price (USD/Unit) of Manufacturers (2014-2020)
6.7.4 Southeast Asia Cancer Drugs Gross Margin of Manufacturers (2014-2020)
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Cancer Drugs Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.8.2 South America Cancer Drugs Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.8.3 South America Cancer Drugs Price (USD/Unit) of Manufacturers (2014-2020)
6.8.4 South America Cancer Drugs Gross Margin of Manufacturers (2014-2020)
6.8.5 Market Concentration
7 Global Cancer Drugs Market Assessment by Regions
7.1 Global Cancer Drugs Capacity (K Units) and Market Share by Regions (2014-2020)
7.2 Global Cancer Drugs Sales (K Units) and Market Share by Regions (2014-2020)
7.3 Global Cancer Drugs Revenue (M USD) and Market Share by Regions (2014-2020)
7.4 Global Cancer Drugs Price (USD/Unit) by Regions (2014-2020)
7.5 Global Cancer Drugs Gross Margin by Regions (2014-2020)
8 Capacity Analysis of Different Regions
8.1 Global Cancer Drugs Capacity and Growth Rate (2014-2020)
8.2 China Cancer Drugs Capacity and Growth Rate (2014-2020)
8.3 USA Cancer Drugs Capacity and Growth Rate (2014-2020)
8.4 Europe Cancer Drugs Capacity and Growth Rate (2014-2020)
8.5 Japan Cancer Drugs Capacity and Growth Rate (2014-2020)
8.6 Korea Cancer Drugs Capacity and Growth Rate (2014-2020)
8.7 India Cancer Drugs Capacity and Growth Rate (2014-2020)
8.8 Southeast Asia Cancer Drugs Capacity and Growth Rate (2014-2020)
8.9 South America Cancer Drugs Capacity and Growth Rate (2014-2020)
9 Technology and Cost Analysis
9.1 Technology
9.2 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution of Global Cancer Drugs Major Manufacturers
11 Global Cancer Drugs Market Forecast by Regions
11.1 Global Cancer Drugs Market Forecast (2021-2026)
11.1.1 Global Cancer Drugs Capacity Forecast by Regions (2021-2026)
11.1.2 Global Cancer Drugs Sales Forecast by Regions (2021-2026)
11.1.2 Global Cancer Drugs Revenue Forecast by Regions (2021-2026)
11.2 China Cancer Drugs Market Forecast (2021-2026)
11.3 USA Cancer Drugs Market Forecast (2021-2026)
11.4 Europe Cancer Drugs Market Forecast (2021-2026)
11.5 Japan Cancer Drugs Market Forecast (2021-2026)
11.6 Korea Cancer Drugs Market Forecast (2021-2026)
11.7 India Cancer Drugs Market Forecast (2021-2026)
11.8 Southeast Asia Cancer Drugs Market Forecast (2021-2026)
11.9 South America Cancer Drugs Market Forecast (2021-2026)
12 Global Cancer Drugs Market Forecast by Types (2021-2026)
12.1 Overall Market Performance (Sales, Revenue)
12.2 Chemotherapy
12.3 Targeted Therapy
12.4 Immunotherapy
12.5 Hormonal Therapy (Biologic Therapy)
12.6 Others
13 Global Cancer Drugs Market Forecast by Application (2021-2026)
13.1 Overall Market Performance (Sales and Growth Rate)
13.2 Blood Cancer
13.3 Breast Cancer
13.4 Gastrointestinal Cancer
13.5 Prostate Cancer
13.6 Respiratory/Lung Cancer
13.7 Other Cancers
14 Global Price (USD/Unit) and Gross Profit Forecast
14.1 Global Cancer Drugs Average Price Forecast (2021-2026)
14.2 Global Cancer Drugs Gross Profit Forecast (2021-2026)
15 Conclusion
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 221 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 260 |
Price : US$ 3,500 | Date : Jan 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 143 |
Price : US$ 3,500 | Date : Jan 2024 |
Category : Medical Devices | Pages : 123 |
Price : US$ 3,500 | Date : Jan 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 117 |
We will be happy to help you find what you need. Please call us or write to us: